Pharmacy Times

JULY 16, 2025

Tarlatamab established a new standard for relapsed SCLC, with improved survival and easier administration, enhancing treatment accessibility. Zanubrutinib demonstrated sustained efficacy in CLL with del(17p), emphasizing the importance of BTK inhibitors in high-risk hematologic malignancies.

HIV Treatment and Prevention Agents 65

HIV Treatment and Prevention Agents Compounding Pharmacies Immunization Chemotherapy 65

Pharmacy Times

JULY 18, 2025

Image credit: OM | stock.adobe.com Why Proper Disposal Matters Disposing of medications appropriately helps prevent environmental contamination of water and soil. Pharmacists should recommend proper disposal guidance and explain the possible consequences of improper disposal.

HIV Treatment and Prevention Agents 50

HIV Treatment and Prevention Agents Compounding Pharmacies Compounding Immunization 50

Pharmacy Times

JULY 19, 2025

Malesker, PharmD, FCCP, FCCM, FASHP, BCPS +1 More Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action. Jansen, PharmD Candidate , Mark A. 2,3 Hypertension remains a major public health challenge both in the United States and globally.

HIV Treatment and Prevention Agents 56

HIV Treatment and Prevention Agents Compounding Pharmacies Vaccines Immunization 56

Pharmacy Times

JULY 1, 2025

Tafamidis, a selective transthyretin stabilizer, significantly reduces mortality and hospitalizations in ATTR-CM patients. SHOW MORE Pharmacists can help oversee the treatment process to ensure patients with transthyretin amyloid cardiomyopathy (ATTR-CM) are adhering to tafamidis.

HIV Treatment and Prevention Agents 111

HIV Treatment and Prevention Agents Specialty Pharmacies Compounding Pharmacies Hospitals 111

Pharmacy Times

JUNE 16, 2025

Although the use of colony-stimulating factors (CSFs) is well-established in mitigating severe FN, existing literature suggests there is only an approximate 3% difference in FN rates between various CSF agents. Utilizing colony-stimulating factors (CSFs) decreases the incidence of severe FN.

HIV Treatment and Prevention Agents 73

HIV Treatment and Prevention Agents Chemotherapy Compounding Pharmacies Immunization 73

Pharmacy Times

JUNE 10, 2025

The convenience of once-daily dosing and a rapid IV bolus administration may offer workflow efficiencies in hospital or surgical settings, where minimizing polypharmacy and streamlining medication administration are important goals. 2 REFERENCES 1.

FDA 73

FDA HIV Treatment and Prevention Agents Compounding Pharmacies Hospitals 73

Pharmacy Times

JUNE 23, 2025

The presentation emphasized early intervention and personalized treatment plans in managing type 2 diabetes, shifting from "treating to failure" to "treating to target." It is not indicated for type 1 diabetes and carries a boxed warning for thyroid C-cell tumors, with unknown risk in humans.

HIV Treatment and Prevention Agents 81

HIV Treatment and Prevention Agents Compounding Pharmacies Immunization FDA 81